Fig. 3
a: Computed Tomography (CT) scan in February after treatment with a PD-L1 inhibitor. b: CT scan showing smaller lesions in April 2018 after treatment with Sorafenib
Fig. 3 | Journal for ImmunoTherapy of Cancer
a: Computed Tomography (CT) scan in February after treatment with a PD-L1 inhibitor. b: CT scan showing smaller lesions in April 2018 after treatment with Sorafenib